Mckesson Corp

More Details of Mckesson Corp Company

McKesson Corporation is a provider of diversified healthcare services. It is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.

Company Info

Ticker SymbolMCK

Company nameMcKesson Corp

IPO dateNov 10, 1994

CEOMr. Brian Scott Tyler, Ph.D.

Number of employees43000

Security typeOrdinary Share

Fiscal year-endNov 10

Address6555 State Highway 161

CityIRVING

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code75039

Phone19724464800

Websitehttps://www.mckesson.com/

Ticker SymbolMCK

IPO dateNov 10, 1994

CEOMr. Brian Scott Tyler, Ph.D.

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Britt J. Vitalone

Chief Financial Officer, Executive Vice President

14.58K

+0.01%

Mr. Brian Scott Tyler, Ph.D.

Chief Executive Officer, Director

4.23K

-84.95%

Ms. Michele Lau

Executive Vice President, Chief Legal Officer

3.38K

+14.90%

Ms. Leann B. Smith

Chief Human Resources Officer, Executive Vice President

2.80K

+166.41%

Mr. Thomas L. (Tom) Rodgers

Executive Vice President, Chief Strategy and Business Development Officer

2.54K

--

Mr. Donald R. (Don) Knauss

Independent Chairman of the Board

2.07K

--

Mr. Dominic J. Caruso

Independent Director

650.00

+86.25%

Ms. Kathleen Wilson - Thompson

Independent Director

301.00

--

Mr. James H. Hinton

Independent Director

--

Mr. Kevin M. Ozan

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Britt J. Vitalone

Chief Financial Officer, Executive Vice President

14.58K

+0.01%

Mr. Brian Scott Tyler, Ph.D.

Chief Executive Officer, Director

4.23K

-84.95%

Ms. Michele Lau

Executive Vice President, Chief Legal Officer

3.38K

+14.90%

Ms. Leann B. Smith

Chief Human Resources Officer, Executive Vice President

2.80K

+166.41%

Mr. Thomas L. (Tom) Rodgers

Executive Vice President, Chief Strategy and Business Development Officer

2.54K

--

Mr. Donald R. (Don) Knauss

Independent Chairman of the Board

2.07K

--

Revenue Breakdown

Currency: USDUpdated: Fri, Feb 21

FY2020

FY2019

No Data

By RegionUSD

Name

Revenue

Proportion

United States

192.71B

83.41%

Foreign

38.34B

16.59%

By Business

By Region

No Data

Shareholding Stats

Updated: Tue, Aug 19

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

9.66%

BlackRock Institutional Trust Company, N.A.

5.42%

State Street Global Advisors (US)

4.58%

MFS Investment Management

3.15%

JP Morgan Asset Management

2.77%

Other

74.42%

Shareholders

Proportion

The Vanguard Group, Inc.

9.66%

BlackRock Institutional Trust Company, N.A.

5.42%

State Street Global Advisors (US)

4.58%

MFS Investment Management

3.15%

JP Morgan Asset Management

2.77%

Other

74.42%

Shareholder Types

Shareholders

Proportion

Investment Advisor

47.41%

Investment Advisor/Hedge Fund

30.83%

Pension Fund

2.99%

Research Firm

2.61%

Hedge Fund

2.45%

Bank and Trust

2.15%

Sovereign Wealth Fund

1.59%

Family Office

0.48%

Family Office

0.41%

Other

9.08%

Institutional Shareholding

Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

2898

111.75M

89.83%

-2.74M

2025Q1

2904

112.96M

90.43%

-4.50M

2024Q4

2760

112.22M

89.53%

-6.16M

2024Q3

2646

112.88M

88.88%

-6.35M

2024Q2

2612

114.72M

88.46%

-4.02M

2024Q1

2547

114.60M

88.11%

-6.25M

2023Q4

2490

116.65M

88.75%

-6.75M

2023Q3

2349

117.73M

88.45%

-6.84M

2023Q2

2305

118.79M

88.02%

-5.64M

2023Q1

2246

120.64M

88.65%

-5.49M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

11.78M

9.43%

-44.33K

-0.37%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

6.57M

5.26%

-15.06K

-0.23%

Mar 31, 2025

State Street Global Advisors (US)

5.69M

4.56%

-17.36K

-0.30%

Mar 31, 2025

MFS Investment Management

4.54M

3.63%

-123.39K

-2.65%

Mar 31, 2025

JP Morgan Asset Management

3.07M

2.46%

-90.11K

-2.85%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.71M

2.17%

+45.20K

+1.70%

Mar 31, 2025

Putnam Investment Management, L.L.C.

2.43M

1.95%

+95.40K

+4.08%

Mar 31, 2025

Fidelity Management & Research Company LLC

1.37M

1.1%

-732.42K

-34.86%

Mar 31, 2025

Norges Bank Investment Management (NBIM)

2.11M

1.69%

-176.84K

-7.75%

Dec 31, 2024

Related ETFs

Updated: Sat, Sep 6

Name

Proportion

VanEck Pharmaceutical ETF

6.13%

VanEck Retail ETF

4.26%

First Trust Consumer Staples Alphadex Fund

3.88%

Texas Capital Texas Equity Index ETF

3.86%

iShares US Consumer Staples ETF

3.82%

SMI 3Fourteen Full-Cycle Trend ETF

3.66%

Janus Henderson US Sustainable Equity ETF

3.41%

Alger 35 ETF

3.29%

Invesco Dorsey Wright Consumer Cyclicals Momentum ETF

3.01%

JPMorgan Healthcare Leaders ETF

2.83%

VanEck Pharmaceutical ETF

Proportion6.13%

VanEck Retail ETF

Proportion4.26%

First Trust Consumer Staples Alphadex Fund

Proportion3.88%

Texas Capital Texas Equity Index ETF

Proportion3.86%

iShares US Consumer Staples ETF

Proportion3.82%

SMI 3Fourteen Full-Cycle Trend ETF

Proportion3.66%

Janus Henderson US Sustainable Equity ETF

Proportion3.41%

Alger 35 ETF

Proportion3.29%

Invesco Dorsey Wright Consumer Cyclicals Momentum ETF

Proportion3.01%

JPMorgan Healthcare Leaders ETF

Proportion2.83%

Dividend

A total of 1.50B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 30, 2025

MCK.NB Interim Cash Dividend of gross USD 0.71 paid on Apr 01, 2025 going ex on Mar 03, 2025

Mar 03, 2025

Apr 01, 2025

Mar 03, 2025

Oct 31, 2024

MCK.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 02, 2025 going ex on Dec 02, 2024

Dec 02, 2024

Jan 02, 2025

Dec 02, 2024

Aug 01, 2024

MCK.NB Final Cash Dividend of gross USD 0.71 paid on Oct 01, 2024 going ex on Aug 30, 2024

Sep 02, 2024

Oct 01, 2024

Aug 30, 2024

Apr 24, 2024

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Jul 01, 2024 going ex on Jun 03, 2024

Jun 03, 2024

Jul 01, 2024

Jun 03, 2024

Feb 01, 2024

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Apr 01, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Oct 26, 2023

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Jan 02, 2024 going ex on Nov 30, 2023

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Jul 24, 2023

MCK.NB Final Cash Dividend of gross USD 0.62 paid on Oct 02, 2023 going ex on Aug 31, 2023

Sep 01, 2023

Oct 02, 2023

Aug 31, 2023

Apr 27, 2023

MCK.NB Interim Cash Dividend of gross USD 0.54 paid on Jul 03, 2023 going ex on May 31, 2023

Jun 01, 2023

Jul 03, 2023

May 31, 2023

Jan 26, 2023

MCK.NB Interim Cash Dividend of gross USD 0.54 paid on Apr 03, 2023 going ex on Feb 28, 2023

Mar 01, 2023

Apr 03, 2023

Feb 28, 2023

Oct 27, 2022

MCK.NB Interim Cash Dividend of gross USD 0.54 paid on Jan 03, 2023 going ex on Nov 30, 2022

Dec 01, 2022

Jan 03, 2023

Nov 30, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

760.550USD

Mckesson Corp

760.550

Overview

Company

Financials

Analysis